Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Inherit Metab Dis ; 40(4): 555-567, 2017 07.
Artigo em Inglês | MEDLINE | ID: mdl-28643139

RESUMO

Cysteamine is a small aminothiol endogenously derived from coenzyme A degradation. For some decades, synthetic cysteamine has been employed for the treatment of cystinosis, and new uses of the drug continue to emerge. In this review, we discuss the role of cysteamine in cellular and extracellular homeostasis and focus on the potential use of aminothiols to reconstitute the function of proteins harboring arginine (Arg) to cysteine (Cys) mutations, via repair of the Cys residue into a moiety that introduces an amino group, as seen in basic amino acid residues Lys and Arg. Cysteamine has been utilized in vitro and ex vivo in four different genetic disorders, and thus provides "proof of principle" that aminothiols can modify Cys residues. Other aminothiols such as mercaptoethylguanidine (MEG) with closer structural resemblance to the guanidinium moiety of Arg are under examination for their predicted enhanced capacity to reconstitute loss of function. Although the use of aminothiols holds clinical potential, more studies are required to refine specificity and treatment design. The efficacy of aminothiols to target proteins may vary substantially depending on their specific extracellular and intracellular locations. Redox potential, pH, and specific aminothiol abundance in each physiological compartment are expected to influence the reactivity and turnover of cysteamine and analogous drugs. Upcoming research will require the use of suitable cell and animal models featuring Arg to Cys mutations. Since, in general, Arg to Cys changes comprise about 8% of missense mutations, repair of this specific mutation may provide promising avenues for many genetic diseases.


Assuntos
Arginina/química , Cisteamina/química , Cisteína/química , Cistinose/terapia , Mutação , Animais , Apolipoproteína E3/metabolismo , Argininossuccinato Liase/metabolismo , Cistationina beta-Sintase/metabolismo , Cistinose/genética , Cistinose/metabolismo , Homeostase , Humanos , Concentração de Íons de Hidrogênio , Conformação Molecular , Mutação de Sentido Incorreto , Oxirredução , Compostos de Sulfidrila/química , Tromboplastina/metabolismo
2.
Free Radic Biol Med ; 96: 1-12, 2016 07.
Artigo em Inglês | MEDLINE | ID: mdl-27083476

RESUMO

Accumulation of toxic metabolites has been described to inhibit mitochondrial enzymes, thereby inducing oxidative stress in propionic acidemia (PA), an autosomal recessive metabolic disorder caused by the deficiency of mitochondrial propionyl-CoA carboxylase. PA patients exhibit neurological deficits and multiorgan complications including cardiomyopathy. To investigate the role of mitochondrial dysfunction in the development of these alterations we have used a hypomorphic mouse model of PA that mimics the biochemical and clinical hallmarks of the disease. We have studied the tissue-specific bioenergetic signature by Reverse Phase Protein Microarrays and analysed OXPHOS complex activities, mtDNA copy number, oxidative damage, superoxide anion and hydrogen peroxide levels. The results show decreased levels and/or activity of several OXPHOS complexes in different tissues of PA mice. An increase in mitochondrial mass and OXPHOS complexes was observed in brain, possibly reflecting a compensatory mechanism including metabolic reprogramming. mtDNA depletion was present in most tissues analysed. Antioxidant enzymes were also found altered. Lipid peroxidation was present along with an increase in hydrogen peroxide and superoxide anion production. These data support the hypothesis that oxidative damage may contribute to the pathophysiology of PA, opening new avenues in the identification of therapeutic targets and paving the way for in vivo evaluation of compounds targeting mitochondrial biogenesis or reactive oxygen species production.


Assuntos
Metilmalonil-CoA Descarboxilase/genética , Mitocôndrias/genética , Estresse Oxidativo/genética , Acidemia Propiônica/genética , Animais , Antioxidantes/metabolismo , DNA Mitocondrial/genética , Modelos Animais de Doenças , Homeostase , Humanos , Peróxido de Hidrogênio/metabolismo , Peroxidação de Lipídeos/genética , Metilmalonil-CoA Descarboxilase/metabolismo , Camundongos , Mitocôndrias/metabolismo , Mitocôndrias/patologia , Oxirredução , Acidemia Propiônica/patologia , Análise Serial de Proteínas , Espécies Reativas de Oxigênio/metabolismo , Superóxidos/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...